X
Navigation Menu
Products
Services
Tools
Resources
logo
AAT Bioquest

 
search
logo
AAT Bioquest
Contact us
Company
Telephone:1-408-733-1055
Fax:1-408-733-1304
Hours:Monday to Friday
8:30 - 17:30 PST (GMT-8)
Location:5775 W Las Positas Blvd.
Pleasanton, CA, 94588
USA

Email us
Sales:sales@aatbio.com
Technical Support:support@aatbio.com
Website:websupport@aatbio.com
General Inquiries:info@aatbio.com
Order info
United States of America
Telephone:1-408-733-1055
Fax:1-408-733-1304
Email:sales@aatbio.com
Purchase Order:sales@aatbio.com

International
Click here to see all available distributors
Products
Services
Tools
Resources
 
search
calculatorCalculator

Matrix metalloproteinase 3 Inhibitors (IC50, Ki)

Structure
▲
▼
Compound Name
▲
▼
Standard Type
▲
▼
Standard Values (in nM)
▲
▼
(2R)-N-Hydroxy-2-[(4-methoxyphenyl)sulfonyl-(pyridin-3-ylmethyl)amino]-3-methylbutanamide;hydrochlorideIC5016.9 [1]
(2R)-N-Hydroxy-2-[(4-methoxyphenyl)sulfonyl-(pyridin-3-ylmethyl)amino]-3-methylbutanamide;hydrochlorideKi43.0 [1]
MarimastatIC5025.0 [1]
MarimastatKi2.4 [1], 8.9 [2], 84.0 [3]
IlomastatIC507.0 [1]
IlomastatKi26.0 [1], 46.0 [2]
PrinomastatIC500.23 [1], 1.1 [2], 3.5 [3], 4.9 [4]
PrinomastatKi0.27 [1]
(2R)-2-[[(2S)-1-[[(2S)-1-Anilino-4-methyl-1-oxopentan-2-yl]amino]-1-oxo-4-phenylbutan-2-yl]amino]propanoic acidIC50320.0 [1]
(2R)-2-[[(2S)-1-[[(2S)-1-Anilino-4-methyl-1-oxopentan-2-yl]amino]-1-oxo-4-phenylbutan-2-yl]amino]propanoic acidKi467.74 [1]
4-[4-(4-Chloro-phenoxy)-benzenesulfonylmethyl]-tetrahydro-pyran-4-carboxylic acid hydroxyamideIC500.3 [1], 7.1 [2]
4-[4-(4-Chloro-phenoxy)-benzenesulfonylmethyl]-tetrahydro-pyran-4-carboxylic acid hydroxyamideKi9.3 [1]
(R)-3-[[[(S)-2-Phenyl-1-(N-methylcarbamoyl)ethyl]amino]carbonyl]-8-phenoxyoctanehydroximic acidIC5014.0 [1]
(R)-3-[[[(S)-2-Phenyl-1-(N-methylcarbamoyl)ethyl]amino]carbonyl]-8-phenoxyoctanehydroximic acidKi14.0 [1], 14.13 [2], 100.0 [3]
BatimastatIC500.56 [1], 0.65 [2], 0.73 [3], 0.75 [4], 20.0 [5]
Methylamino-phenylalanyl-leucyl-hydroxamic acidIC5043.0 [1]
Methylamino-phenylalanyl-leucyl-hydroxamic acidKi79.0 [1], 79.43 [2], 89.0 [3]
(R)-3-[[[(S)-2-Phenyl-1-(N-methylcarbamoyl)ethyl]amino]carbonyl]-7-(benzyloxy)heptanehydroximic acidKi15.0 [1], 15.14 [2], 100.0 [3]
(R)-3-[[[(S)-2-Phenyl-1-(N-methylcarbamoyl)ethyl]amino]carbonyl]-7-phenoxyheptanehydroximic acidKi28.0 [1], 28.18 [2], 100.0 [3]
CipemastatIC5087.0 [1], 527.0 [2]
CipemastatKi56.0 [1], 527.0 [2]
CarbobenzoxyphenylalanineIC5040000.0 [1], 99000.0 [2]
CarbobenzoxyphenylalanineKi33000.0 [1], 83000.0 [2]
BenzyloxycarbonyltryptophanIC502500.0 [1], 7500.0 [2]
BenzyloxycarbonyltryptophanKi2100.0 [1], 6300.0 [2]
N-Hydroxy-2-(N-isopropoxybiphenyl-4-ylsulfonamido)acetamideIC504500.0 [1], 5900.0 [2]
CID 6914621IC50141.0 [1]
CID 6914621Ki141.0 [1]
N-Benzyloxycarbonyl-L-tyrosineIC5022000.0 [1], 24000.0 [2]
N-Benzyloxycarbonyl-L-tyrosineKi18000.0 [1], 20000.0 [2]
CID 10370504IC505.89 [1], 5.9 [2]
Mmp inhibitor IIIC5018.4 [1], 28.6 [2]
Mmp inhibitor IIKi18.0 [1]
N-(3-Methoxybenzyl)-4-Oxo-3,4-Dihydroquinazoline-2-CarboxamideIC5010000.0 [1]
(2R)-1-N-Hydroxy-2-N-[(2S)-1-(methylamino)-1-oxo-3-phenylpropan-2-yl]-5-N-(2-phenylethyl)pentane-1,2,5-tricarboxamideKi6.0 [1], 6.03 [2], 100.0 [3]
(R)-3-[[[(S)-2-Phenyl-1-(N-methylcarbamoyl)ethyl]amino]carbonyl]-6-(benzyloxy)hexanehydroximic acidKi42.66 [1], 43.0 [2], 100.0 [3]
(2R)-5-N-Benzyl-1-N-hydroxy-2-N-[(2S)-1-(methylamino)-1-oxo-3-phenylpropan-2-yl]pentane-1,2,5-tricarboxamideKi91.2 [1], 92.0 [2], 100.0 [3]
(2R)-2-[[(2S)-1-[[(2S)-1-Anilino-4-methyl-1-oxopentan-2-yl]amino]-1-oxo-4-(4-propylphenyl)butan-2-yl]amino]propanoic acidKi18.0 [1], 18.2 [2]
5-[(2-Amino-3-phenylpropanoyl)amino]-N-hydroxy-7-methyl-3-(2-methylpropyl)-4-oxooctanamideIC5016.0 [1], 18.0 [2]
5-[(2-Amino-3-phenylpropanoyl)amino]-N-hydroxy-7-methyl-3-(2-methylpropyl)-4-oxooctanamideKi13.0 [1], 15.0 [2]
Z-D-Trp-OHIC5086000.0 [1], 287000.0 [2]
Z-D-Trp-OHKi71000.0 [1], 241000.0 [2]
(R)-2-(((Benzyloxy)carbonyl)amino)-3-(4-hydroxyphenyl)propanoic acidIC50432000.0 [1], 450000.0 [2]
(R)-2-(((Benzyloxy)carbonyl)amino)-3-(4-hydroxyphenyl)propanoic acidKi356000.0 [1], 377000.0 [2]
2-((4-Phenoxyphenylsulfonyl)methyl)thiiraneKi15000.0 [1]
N-Isobutyl-N-[4-methoxyphenylsulfonyl]glycyl hydroxamic acidIC506500.0 [1]
N-Isobutyl-N-[4-methoxyphenylsulfonyl]glycyl hydroxamic acidKi131.83 [1], 133.0 [2]
(S)-2-(4'-Bromo-[1,1'-biphenyl]-4-ylsulfonamido)-3-methylbutanoic acidIC507.0 [1], 12.0 [2]
(S)-2-(4'-Bromo-[1,1'-biphenyl]-4-ylsulfonamido)-3-methylbutanoic acidKi4.4 [1]
2-[3-(5-Mercapto-[1,3,4]thiadiazol-2YL)-ureido]-N-methyl-3-pentafluorophenyl-propionamideKi18.0 [1]
2-[3-(5-Mercapto-[1,3,4]thiadiazol-2-YL)-ureido]-N-methyl-3-phenyl-propionamideKi707.95 [1], 710.0 [2]
3-[(4'-Cyanobiphenyl-4-Yl)oxy]-N-HydroxypropanamideIC5025.0 [1], 47.0 [2], 57.0 [3]
(2R)-N-[(2S)-3,3-Dimethyl-1-oxo-1-[[(1R)-1-phenylethyl]amino]butan-2-yl]-N'-hydroxy-2-(3-phenylpropyl)butanediamideIC508.91 [1], 40.0 [2]
(6S,7R,10S)-6-N-Hydroxy-10-N-methyl-7-(2-methylpropyl)-8-oxo-2-oxa-9-azabicyclo[10.2.2]hexadeca-1(14),12,15-triene-6,10-dicarboxamideIC507.8 [1]
(6S,7R,10S)-6-N-Hydroxy-10-N-methyl-7-(2-methylpropyl)-8-oxo-2-oxa-9-azabicyclo[10.2.2]hexadeca-1(14),12,15-triene-6,10-dicarboxamideKi32.7 [1]
(2R)-N-[(2S)-3,3-Dimethyl-1-(methylamino)-1-oxobutan-2-yl]-N'-hydroxy-2-(3-phenylpropyl)butanediamideIC5047.86 [1], 48.0 [2]
(2S)-2-[[4-(4-Methoxyphenyl)phenyl]sulfonylamino]-3-methylbutanoic acidIC508.0 [1], 1890.0 [2]
(2R,3R)-1-[4-[(2-Chloro-4-fluorophenyl)methoxy]phenyl]sulfonyl-N,3-dihydroxy-3-methylpiperidine-2-carboxamideIC503.0 [1], 5.0 [2]
(2R)-2-[[(2S)-1-[[(2S)-1-Anilino-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1-oxo-4-phenylbutan-2-yl]amino]propanoic acidKi229.09 [1], 230.0 [2]
Benzyl 6-Benzyl-5,7-Dioxo-6,7-Dihydro-5h-[1,3]thiazolo[3,2-C]pyrimidine-2-CarboxylateIC5030000.0 [1], 100000.0 [2]
(2R,3R)-3-(Cyclopentylmethyl)-N-hydroxy-2-[[methyl(methylsulfonyl)amino]methyl]-4-oxo-4-piperidin-1-ylbutanamideIC50199.53 [1], 200.0 [2]
3-Hydroxy-N-methyl-2-[3-(5-thioxo-4,5-dihydro-[1,3,4]thiadiazol-2-yl)-ureido]-propionamideKi30902.95 [1], 31000.0 [2]
N-Methyl-2-[3-(5-thioxo-4,5-dihydro-[1,3,4]thiadiazol-2-yl)-ureido]-acetamideKi165958.69 [1], 166000.0 [2]
N-Hydroxy-1-(4-methoxyphenyl)sulfonylpiperazine-2-carboxamideIC5048.0 [1]
(3R)-2-[Ethoxy-(4-methoxyphenyl)phosphoryl]-N-hydroxy-3,4-dihydro-1H-isoquinoline-3-carboxamideKi5.2 [1]
Tert-butyl (6S,9R,10S)-10-(hydroxycarbamoyl)-6-(methylcarbamoyl)-9-(2-methylpropyl)-8-oxo-1,7-diazacyclotridecane-1-carboxylateKi1.0 [1], 3.0 [2]
(3S)-N-Hydroxy-4-(4-methoxyphenyl)sulfonyl-2,2-dimethyl-1,1-dioxo-1,4-thiazepane-3-carboxamideIC506.9 [1], 6.92 [2]
(6S,7S)-N-Hydroxy-6-[(4-phenylpiperazin-1-yl)carbonyl]-5-azaspiro[2.5]octane-7-carboxamideIC505000.0 [1]
(2R)-N-[(2S)-1-(Benzhydrylamino)-3,3-dimethyl-1-oxobutan-2-yl]-N'-hydroxy-2-(3-phenylpropyl)butanediamideIC5047.86 [1], 48.0 [2]
(S)-N-Hydroxy-4-(4-methoxyphenylsulfonyl)-2,2-dimethyl-1,4-thiazepane-3-carboxamideIC500.7 [1], 0.71 [2]
(R)-3-[[[(S)-2-Phenyl-1-(N-methylcarbamoyl)ethyl]amino]carbonyl]-7-hydroxyheptanehydroximic acidKi2187.76 [1], 2200.0 [2]
(R)-3-[[[(S)-2-Phenyl-1-(N-methylcarbamoyl)ethyl]amino]carbonyl]-8-hydroxyoctanehydroximic acidKi426.58 [1], 430.0 [2]
(2R)-1-N-Hydroxy-2-N-[(2S)-1-(methylamino)-1-oxo-3-phenylpropan-2-yl]-5-N-propylpentane-1,2,5-tricarboxamideKi360.0 [1], 363.08 [2]
(2R)-N-[(2S)-3-Cyclohexyl-1-oxo-1-(2-phenylethylamino)propan-2-yl]-N'-hydroxy-2-(3-phenylpropyl)butanediamideKi8.3 [1]
(2S)-2-[[(2S)-2-[[(2R)-2-Aminopropanoyl]amino]-4-phenylbutanoyl]amino]-4-methyl-N-phenylpentanamideIC50320.0 [1]
(2S)-2-[[(2S)-2-[[(2R)-2-Aminopropanoyl]amino]-4-phenylbutanoyl]amino]-4-methyl-N-phenylpentanamideKi6.5 [1], 470.0 [2]
(2R)-4-(1,3-Dioxobenzo[f]isoindol-2-yl)-2-[[(2S)-4-methyl-1-[[(2S)-1-(methylamino)-1-oxo-3-phenylpropan-2-yl]amino]-1-oxopentan-2-yl]amino]butanoic acidIC5090.0 [1], 91.0 [2]
(2R)-4-(1,3-Dioxobenzo[f]isoindol-2-yl)-2-[[(2S)-4-methyl-1-[[(2S)-1-(methylamino)-1-oxo-3-phenylpropan-2-yl]amino]-1-oxopentan-2-yl]amino]butanoic acidKi20.0 [1]
N-Hydroxy-2(R)-[[(4-methoxyphenyl)sulfonyl](3-picolyl)amino]-3-methylbutanamide hydrochlorideIC5030.0 [1]
TanomastatIC50134.0 [1]
TanomastatKi143.0 [1]
(R)-N1-((S)-3,3-Dimethyl-1-(methylamino)-1-oxobutan-2-yl)-N4-hydroxy-2-isobutylsuccinamideIC50470.0 [1]
(R)-N1-((S)-3,3-Dimethyl-1-(methylamino)-1-oxobutan-2-yl)-N4-hydroxy-2-isobutylsuccinamideKi310.0 [1]
(2S,3R)-N-Hydroxy-N'-[(2S)-1-(methylamino)-1-oxo-3-phenylpropan-2-yl]-3-(2-methylpropyl)-2-prop-2-enylbutanediamideIC5012.0 [1]
ApratastatIC5010.0 [1]
n-[3-(n'-Hydroxycarboxamido)-2-(2-methylpropyl)-propanoyl]-o-tyrosine-n-methylamideIC5030.0 [1]
n-[3-(n'-Hydroxycarboxamido)-2-(2-methylpropyl)-propanoyl]-o-tyrosine-n-methylamideKi10.0 [1]
Unii-Q56UE7E40YIC503560.0 [1], 4000.0 [2]
N-[(Tert-Butoxy)carbonyl]-L-tryptophanIC5010000.0 [1]
N-[(Tert-Butoxy)carbonyl]-L-tryptophanKi8000.0 [1]
(R)-5-(6-Cyclohexyl-1-(hydroxyamino)-1-oxohexan-3-yl)-1,2,4-oxadiazole-3-carboxamideIC5010000.0 [1]
(R)-N-Hydroxy-2-(N-isopropoxybiphenyl-4-ylsulfonamido)-3-methylbutanamideIC5050.0 [1]
cis-2-Aminocyclohexylcarbamoylphosphonic acidIC50100000.0 [1]
(3R)-3-[[(2S)-1-[[(1S)-2-Methoxy-1-phenylethyl]amino]-3,3-dimethyl-1-oxobutan-2-yl]carbamoyl]-6-(3-methyl-4-phenylphenyl)hexanoic acidIC5023.0 [1]
N-[(2S)-1-(4,4-Dimethyl-2,5-dioxoimidazolidin-1-yl)-3-[4-[4-(trifluoromethoxy)phenyl]phenoxy]propan-2-yl]-N-hydroxyformamideIC5042.0 [1]
N-Hydroxy-1-(2-methoxyethyl)-4-[4-[4-(trifluoromethoxy)phenoxy]phenyl]sulfonylpiperidine-4-carboxamideIC5028.7 [1], 29.0 [2]
4-{[1-Methyl-2,4-Dioxo-6-(3-Phenylprop-1-Yn-1-Yl)-1,4-Dihydroquinazolin-3(2h)-Yl]methyl}benzoic AcidIC5030000.0 [1]
(3R,4R)-N-Hydroxy-4-[[4-[[2-(trifluoromethyl)benzimidazol-1-yl]methyl]benzoyl]amino]oxane-3-carboxamideKi10000.0 [1]
N-Hydroxy-4-(4-phenylsulfanylphenyl)sulfonyl-1-prop-2-ynylpiperidine-4-carboxamideIC5013.0 [1]
4-Benzoyl-N-hydroxy-1-(4-methoxyphenylsulfonyl)piperazine-2-carboxamideIC5066.0 [1], 66.07 [2]
Items per page: 1 - 10 of 100
⟨⟩

References

This online tool may be cited as follows

MLA

"Quest Database™ Matrix metalloproteinase 3 Inhibitors (IC50, Ki)." AAT Bioquest, Inc., 10 May. 2024, https://www.aatbio.com/data-sets/matrix-metalloproteinase-3-inhibitors-ic50-ki.

APA

AAT Bioquest, Inc. (2024, May 10). Quest Database™ Matrix metalloproteinase 3 Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/matrix-metalloproteinase-3-inhibitors-ic50-ki.
BibTeXEndNoteRefMan
Location: Home / Datasets / Matrix metalloproteinase 3 Inhibitors (IC50, Ki)
AboutPrivacyTerms of UseTerms of SalesDistributors
Copyright © 2024 AAT Bioquest, Inc. All Rights Reserved.